Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant SMAD4 anticorps (AA 1-552)

Cet anticorps Lapin Monoclonal détecte spécifiquement SMAD4 dans IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN7126667

Aperçu rapide pour Recombinant SMAD4 anticorps (AA 1-552) (ABIN7126667)

Antigène

Voir toutes SMAD4 Anticorps
SMAD4 (SMAD Family Member 4 (SMAD4))

Type d'anticorp

Recombinant Antibody

Reactivité

  • 94
  • 45
  • 38
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 73
  • 21
  • 1
  • 1
Lapin

Clonalité

  • 58
  • 38
Monoclonal

Conjugué

  • 60
  • 7
  • 7
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SMAD4 est non-conjugé

Application

  • 57
  • 40
  • 30
  • 25
  • 22
  • 10
  • 7
  • 6
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Épitope

    • 13
    • 10
    • 7
    • 5
    • 5
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-552

    Specificité

    Signaling from the ligand-activated membrane receptor serine/threonine kinases to nuclear targets is mediated by a set of evolutionarily conserved proteins known as DPC4. Upon ligand binding, the receptors of the TGF-i² family phosphorylate SMAD proteins (SMAD1 and SMAD2). These proteins then move into the nucleus, where they activate transcription. To carry out this function, the receptor activated SMAD1 and 2 require association with the product of deleted in pancreatic carcinoma, locus 4 (DPC4), also known as SMAD4. SMAD4/DPC4 is also implicated as a tumor suppressor, since it is inactivated in more than half of pancreatic carcinomas and to a lesser extent in a variety of other cancers. The lack of SMAD4 expression is present in approximately 80 % of cases of pancreatic adenocarcinoma, but rarely in endometrial (0 %), colorectal (0 %), ovarian (3 %), lung (0 %), breast (2 %) adenocarcinomas, and malignant melanoma (4 %). SMAD4is an important marker for confirming a diagnosis of pancreatic adenocarcinoma.

    Réactivité croisée (Details)

    Human, mouse, and rat.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant human full-length (aa1-552) SMAD4 protein

    Isotype

    IgG
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human pancreatic ductal adenocarcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    SMAD4 (SMAD Family Member 4 (SMAD4))

    Autre désignation

    SMAD4

    Sujet

    Deleted in Pancreatic Carcinoma 4 (DPC4), JIP, MAD homolog 4 (MADH4), Mothers against decapentaplegic homolog 4 (MADH4), Mothers against DPP homolog 4, MYHRS, SMAD4,SMAD4 / DPC4 (Pancreatic Adenocarcinoma Marker / Tumor Suppressor)
    Cellular localisation: Nucleus. Cytoplasm. Cytoplasmic in absence of ligand. Migrates to nucleus when complexed with R-SMAD.

    Poids moléculaire

    61kDa

    ID gène

    4089, 75862

    UniProt

    Q13485

    Pathways

    Cycle Cellulaire, Chromatin Binding, Autophagy
Vous êtes ici:
Chat with us!